Fundraising FoxThynk Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Repair Biotechnologiesrepairbiotechnologies.cominMay 2019 · $2.1M
Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol.
BiotechHealthtechMedical DevicesSyracuse, US
Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)
BoardKelsey Moody(Director)
PartnerJim Plante· solo GP
Co-investorsquadraScope Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.